# Convalescent Plasma in the Treatment of Covid-19

> **NCT04600440** · NA · UNKNOWN · sponsor: **Skane University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Covid-19
- Respiratory Insufficiency

## Interventions

- **BIOLOGICAL:** Convalescent plasma

## Key facts

- **NCT ID:** NCT04600440
- **Lead sponsor:** Skane University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-25
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-02-28
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04600440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04600440, "Convalescent Plasma in the Treatment of Covid-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04600440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*